We haveenough cashto go wellinto 2023We intendto submita BLA in2H 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Hemorrhoidsis a $2BmarketWe expect tofinish theMino-Loktrial this yearI/ONTAKwas thebest deal Iever madeMyron Holubiakand I founded aprivatecompany in2013Insidersinvested$26.5mAnymentionof Mino-WrapI/ONTAKis our leadassetMino-Lokpotentialmarket>$1BNot manycompaniesthis size with2 late stageassetsOur Halo-Lido trial willhave finalpatient byend of 2022An actualiMSCupdateWe had aphase 2btrial with100%efficacyI'm ashareholdermyselfWe willhaveexclusivityThere are noFDAapproveddrugs to treathemorrhoidsWe will openupinternationalsites forMino-Lok trialOnly biotechwith 2 Myron'son theleadershipteamThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Mino-Lokis our leadassetI won't diluteshareholdersI/ONTAK'spotentialmarket is>$300mWe haveenough cashto go wellinto 2023We intendto submita BLA in2H 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Hemorrhoidsis a $2BmarketWe expect tofinish theMino-Loktrial this yearI/ONTAKwas thebest deal Iever madeMyron Holubiakand I founded aprivatecompany in2013Insidersinvested$26.5mAnymentionof Mino-WrapI/ONTAKis our leadassetMino-Lokpotentialmarket>$1BNot manycompaniesthis size with2 late stageassetsOur Halo-Lido trial willhave finalpatient byend of 2022An actualiMSCupdateWe had aphase 2btrial with100%efficacyI'm ashareholdermyselfWe willhaveexclusivityThere are noFDAapproveddrugs to treathemorrhoidsWe will openupinternationalsites forMino-Lok trialOnly biotechwith 2 Myron'son theleadershipteamThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Mino-Lokis our leadassetI won't diluteshareholdersI/ONTAK'spotentialmarket is>$300m

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. We have enough cash to go well into 2023
  2. We intend to submit a BLA in 2H 2022
  3. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  4. Hemorrhoids is a $2B market
  5. We expect to finish the Mino-Lok trial this year
  6. I/ONTAK was the best deal I ever made
  7. Myron Holubiak and I founded a private company in 2013
  8. Insiders invested $26.5m
  9. Any mention of Mino-Wrap
  10. I/ONTAK is our lead asset
  11. Mino-Lok potential market >$1B
  12. Not many companies this size with 2 late stage assets
  13. Our Halo-Lido trial will have final patient by end of 2022
  14. An actual iMSC update
  15. We had a phase 2b trial with 100% efficacy
  16. I'm a shareholder myself
  17. We will have exclusivity
  18. There are no FDA approved drugs to treat hemorrhoids
  19. We will open up international sites for Mino-Lok trial
  20. Only biotech with 2 Myron's on the leadership team
  21. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  22. Mino-Lok is our lead asset
  23. I won't dilute shareholders
  24. I/ONTAK's potential market is >$300m